| Literature DB >> 30987304 |
Juan Domínguez-Robles1, Niamh K Martin2, Mun Leon Fong3, Sarah A Stewart4, Nicola J Irwin5, María Isabel Rial-Hermida6, Ryan F Donnelly7, Eneko Larrañeta8.
Abstract
Lignin (LIG) is a natural biopolymer with well-known antioxidant capabilities. Accordingly, in the present work, a method to combine LIG with poly(lactic acid) (PLA) for fused filament fabrication applications (FFF) is proposed. For this purpose, PLA pellets were successfully coated with LIG powder and a biocompatible oil (castor oil). The resulting pellets were placed into an extruder at 200 °C. The resulting PLA filaments contained LIG loadings ranging from 0% to 3% (w/w). The obtained filaments were successfully used for FFF applications. The LIG content affected the mechanical and surface properties of the overall material. The inclusion of LIG yielded materials with lower resistance to fracture and higher wettabilities. Moreover, the resulting 3D printed materials showed antioxidant capabilities. By using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, the materials were capable of reducing the concentration of this compound up to ca. 80% in 5 h. This radical scavenging activity could be potentially beneficial for healthcare applications, especially for wound care. Accordingly, PLA/LIG were used to design meshes with different designs for wound dressing purposes. A wound healing model compound, curcumin (CUR), was applied in the surface of the mesh and its diffusion was studied. It was observed that the dimensions of the meshes affected the permeation rate of CUR. Accordingly, the design of the mesh could be modified according to the patient's needs.Entities:
Keywords: 3D printing; antioxidant materials; fused filament fabrication; lignin; wound dressing
Year: 2019 PMID: 30987304 PMCID: PMC6523288 DOI: 10.3390/pharmaceutics11040165
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Scheme of the different meshes produced using FFF.
Figure 2Photographs of: PLA and PLA coated pellets (A); LIG and TC containing PLA filaments (B); LIG and TC containing 1 cm × 1 cm squares prepared using 3D printing (C); and different shapes printed using the filament containing 2% (w/w) LIG (D).
Figure 3Maximum load before fracture for LIG containing filaments (n = 5) (A); and contact angle of water with the surface of 3D printed materials obtained using PLA/LIG composites (n = 4) (B).
Figure 4DSC thermograms obtained for LIG, PLA, castor oil and the resulting PLA/LIG and TC composites (A); expanded view of the thermogram between 60 and 76 °C (B); and T variation as a function of the LIG content (C).
Figure 5Residual DPPH content as a function of time for the LIG containing composites (n = 3) (A); and bacterial adhesion to the PLA/LIG and PLA/LIG/TC composites (n = 3) (B).
Figure 6Experimental setup used to measure drug diffusion trough the 3D printed meshes (A); photographs of the 3D printed meshes made of PLA and 2% (w/w) LIG (B); and CUR release through 1.5 mm (C) and 1 mm (D) 3D printed meshes (n = 3).